Kemin Industries eyes immunity formulations with beta 1,3 glucan from algae following latest US patent

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Ingredient manufacturer Kemin Industries is investing in US-based hemp producer Driftless Extracts and has entered into a hemp-based product supply agreement.

FormattedPicture

NUTRITION & HEALTH NEWS

Weight management has evolved far beyond just losing weight, now including lifestyle changes encompassing healthy eating and mental health. NutritionInsight speaks... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Speciality ingredients manufacturer Galam is investing US$30 million into a new Israel-based production plant for its prebiotic GOFOS.

FormattedPicture

NUTRITION & HEALTH NEWS

Consuming sweeteners during pregnancy could put children more at risk of obesity via changes to their microbiome, despite these changes not occurring in the... Read More

FormattedPicture

FOOD RESEARCH

In its latest partnership, deep tech business Eagle Genomics is teaming up with the UK-based Quadram Institute to investigate the microbiome and its role in diet and... Read More

trans